ZIMMER BIOMET HOLDINGS, INC. (ZBH) Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: Medical - Devices
Zimmer Biomet Holdings, Inc. NYSE:ZBH Healthcare · Medical - Devices
Mkt Cap $19.55B
EV -
SI 4.1%
Net Cash/Sh -
Div Yield 0.93%
CLOSED · Nov 18 +1.20%$103.32 CLOSED · Nov 18 Prev close $102.09 +1.20%Close $103.32 0.00% AH close $103.32 VOL 2.34M $ Vol $241.65M RVOL 0.92x
Mkt Cap $19.55B
EV -
VOL 2.34M sh
$ Vol $241.65M
RVOL 0.92×
SI 4.1%
Net Cash/Sh -
Div Yield 0.93%
Press Release
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
Zimmer Biomet management will present at the Annual Jefferies Global Healthcare Conference in London on Thursday, November 19 at 8:00 a.m. ET. A live webcast will be available on the company's investor relations website, with an archived replay afterward.
• 9d ago AI analysis › Press Release
Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
Zimmer Biomet is introducing Surgeon-Guided Autonomy, a new technology category for intelligent orthopedic surgery, at the AAHKS annual meeting. The framework centers on a closed-loop cycle — Predict, Perform, Recover — that keeps surgeon judgment and control at the center while intelligent systems take on more surgical workload.
• 12d ago AI analysis › Press Release ● Major
Zimmer Biomet Announces Third Quarter 2026 Financial Results
Zimmer Biomet reported Q3 2026 net sales of $2.063 billion, up 3.1% reported and 3.7% constant currency, with diluted EPS of $1.00 (down 13.8%) and adjusted EPS of $1.90, flat year-over-year. Diversification franchises carried the quarter: Hips grew 6.0%, S.E.T. 6.8%, and Technology & Data/Bone Cement/Surgical 11.9%, while Knees declined 3.1%. Free cash flow was $372.4 million on $560.0 million of operating cash flow.
• 14d ago AI analysis › Press Release
Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026
Zimmer Biomet announced plans to preview its vision for intelligent, connected orthopedic surgery at the AAHKS 2026 annual meeting, Nov. 5-8 in the Dallas area, with a featured symposium on Nov. 6. The company will showcase its existing robotics, knee, hip, and connected-care portfolio (including ROSA, Persona, and Persona IQ) at booth #608, but explicitly disclosed no new commercially available product -- statements about the future of surgical robotics are forward-looking only.
• 20d ago AI analysis › Press Release
Arthritis Foundation and Founding Sponsor Zimmer Biomet Announce New Community Celebrating Life After Joint Replacement and Inspiring Others to Act on Severe Joint Pain
Zimmer Biomet is the founding sponsor of the Comeback Club, a new Arthritis Foundation community connecting joint-replacement patients with people considering surgery. The initiative is a patient-awareness and marketing program; no financial terms, spending commitments, or revenue impact are disclosed. The community launches at Arthritis Foundation Jingle Bell Run events in five U.S.
• 23d ago AI analysis › Press Release
Zimmer Biomet India Launches ROSA® Knee with OptimiZe™ in India to Advance Personalized Robotic-Assisted Knee Replacement
Zimmer Biomet launched ROSA Knee with OptimiZe in India, an enhanced version of its robotic-assisted total knee replacement system. The update adds customized surgical planning, reduced landmarking variability, and pin-free cut-guide tracking, and integrates with the ZBEdge analytics platform.
• 23d ago AI analysis › Press Release
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
Zimmer Biomet and THINK Surgical announced a multi-year extension of their Limited Exclusive Distribution and Supply Agreement following a successful initial term. Under the extension, Zimmer Biomet will continue exclusively distributing a customized version of THINK's wireless, handheld TMINI Miniature Robotic System compatible with the Persona Knee System.
• 1mo ago AI analysis › Press Release
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
Zimmer Biomet announced its Q3 2026 earnings conference call will be webcast on November 4, 2026, at 8:30 a.m. ET. The quarterly results news release will be issued the same day at 6:30 a.m. ET, with a live audio webcast on the company's investor relations site.
• 1mo ago AI analysis › Press Release
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Zimmer Biomet announced three executive promotions effective October 1, 2026, to streamline its Americas and Global Business Group organizations. Gary Campbell was promoted to President, Americas; Brian Hatcher to President of Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data.
• 2mo ago AI analysis › Press Release
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
Zimmer Biomet's Board of Directors approved a quarterly cash dividend of $0.24 per share for the third quarter of 2026.
• 2mo ago AI analysis › Press Release
Zimmer Biomet Announces Second Quarter 2026 Financial Results
Zimmer Biomet reported Q2 revenue of $2.18 billion, up 4.8% year-over-year, with adjusted EPS of $2.07, flat compared to the prior year. The company raised its full-year 2026 guidance, projecting revenue growth of 3.9% to 4.9% and adjusted EPS between $8.47 and $8.59, driven by strong first-half performance and market momentum.
• 3mo ago AI analysis › Press Release
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
Zimmer Biomet appointed Chintan Desai as president of the Asia Pacific region, effective immediately. Desai joins from Alcon, where he served as VP and GM of International Growth and Export Markets, and brings nearly three decades of experience from GE Healthcare.
• 4mo ago AI analysis › Press Release
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
Zimmer Biomet scheduled its second quarter 2026 earnings conference call for August 5, 2026, at 8:30 a.m. ET. The full financial results press release will be issued earlier that morning at 6:30 a.m. ET.
• 4mo ago AI analysis › Press Release
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Zimmer Biomet management will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026. The session is scheduled for 10:40 a.m. ET and will be available via live audio webcast on the company's Investor Relations website.
• 5mo ago AI analysis › Press Release
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
Zimmer Biomet declared a quarterly cash dividend of $0.24 per share for the second quarter of 2026. The payment is scheduled for July 31, 2026, to stockholders of record as of June 25, 2026.
• 5mo ago AI analysis › Press Release
Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End
prnewswire.com • 6mo ago Press Release
Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference
Zimmer Biomet announced that members of its management team will participate in the Bank of America Securities 2026 Health Care Conference. The fireside chat is scheduled for Wednesday, May 13, 2026, at 8:40 a.m. PT.
• 6mo ago AI analysis › Press Release ● Major
Zimmer Biomet Announces First Quarter 2026 Financial Results
Zimmer Biomet reported Q1 net sales of $2.09 billion, up 9.3% reported and 2.9% organic constant currency, driven by healthy end markets and new product momentum. Adjusted diluted EPS increased 15.5% to $2.09, leading the company to raise its full-year adjusted EPS guidance to $8.40-$8.55.
• 6mo ago AI analysis › Press Release
Zimmer Biomet Announces Chief Financial Officer Transition
Zimmer Biomet announced that CFO Suketu Upadhyay is departing the company effective immediately to pursue a new professional opportunity. Paul Stellato, currently Controller and Chief Accounting Officer, has been appointed interim CFO while the company conducts a search for a permanent successor.
• 6mo ago AI analysis ›